Kamada Posts 51% Jump in Q3 Net Income and Raises 2026 Revenue Guidance
Kamada reported Q3 2026 revenues of $52 million, an 11% increase, and a 51% surge in net income to $8 million. The biopharmaceutical firm upgraded its annual revenue and EBITDA forecasts and announced a dividend distribution.
Israeli biopharmaceutical company Kamada, traded on the Tel Aviv Stock Exchange and Nasdaq, released its financial results for the third quarter of 2026, reporting strong growth in revenues and profitability alongside an upward revision of its annual forecasts.
Controlled by the FIMI Opportunity Funds, Kamada reported quarterly revenues of $52 million, marking an 11% increase compared to $47 million in the corresponding period last year. Net income surged by 51% to reach $8 million, up from $5.3 million in the parallel quarter, while earnings per share rose from 9 cents to 14 cents.
Adjusted EBITDA grew by 30% to $15.2 million, with the adjusted EBITDA margin reaching 29% of revenues compared to approximately 25% in the same period last year. The strong financial performance was primarily driven by higher sales of proprietary products, led by KEDRAB for rabies post-exposure prophylaxis in the US market, alongside growth in VARIZIG and HEPAGAM sales.
Raised Guidance and Dividend Distribution
Following the robust quarterly performance, Kamada raised its full-year 2026 revenue guidance to a range of $205 million to $208 million, up from its previous forecast of $200 million to $205 million. The adjusted EBITDA guidance was correspondingly upgraded to between $52 million and $54 million, compared to the previous range of $50 million to $53 million.
The company anticipates continued double-digit growth in both revenues and profitability through 2027, with detailed numerical projections slated for publication in January. For the first nine months of the year, revenues reached a record $152.2 million, a 12% increase, while net income grew by 29% to $21.4 million. Operating cash flow more than doubled to $37.6 million.
Concurrently, Kamada announced a dividend distribution of 14 cents per share, totaling approximately $8 million. Together with previous distributions, the cumulative dividend payout for the year will reach $32.2 million.
